NTNX vs ZBRA

Nutanix demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. While the stock is currently in a severe technical downtrend (0/100), the valuation is highly attractive on a growth-adjusted basis with a PEG ratio of 0.86 and a Forward P/E of 17.66. The company maintains elite gross margins of 87.13% and a remarkable track record of beating earnings estimates over 25 consecutive quarters. Despite trading above the growth-based intrinsic value of $28.32, the combination of earnings acceleration and analyst targets suggests a strong recovery potential.

ZBRA exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided. The stock is currently trading at a significant premium to its Graham Number ($115.46) and Intrinsic Value ($57.33), suggesting a high valuation relative to current fundamentals. While the PEG ratio (0.49) and Forward P/E (11.29) indicate strong future growth expectations, these are contrasted by a severe current earnings contraction of -55.8% and bearish technical trends. Liquidity is a primary concern, evidenced by a Quick Ratio of 0.52.